Good Afternoon!
Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.
Bitcoin’s ups and downs have made and lost fortunes. But what if there was a way to outperform BTC—without ever buying it?
Hedge fund titan Larry Benedict has revealed a new approach called "Bitcoin Skimming," a strategy that has outpaced Bitcoin’s returns by as much as 22-to-1.
With the SEC’s latest decision set to shake up crypto markets, now is the perfect time to discover how this works.
Wall Street was dominated by bulls on Friday, driven by a stronger-than-expected increase in nonfarm payrolls. Meanwhile, investors hoped that tensions between the U.S. and China would ease.
|
|
Bunge Global (NYSE: BG) faces a roadblock in its $8.2 billion deal to buy Viterra, as China’s antitrust regulators have not approved the merger.
Announced in June 2023, the deal cleared reviews in Europe and Canada, but China’s delay could cost Bunge a $400 million fee if the merger fails.
Fueled by new tariffs, tensions between the U.S. and China complicate matters. Beijing sees food supply as a key issue, and Bunge’s plan to grow through Viterra might affect grain and oilseed markets. This delay shows how trade disputes can hurt big deals, worrying investors about BG’s stock.
Bunge executives have visited China repeatedly, but approval remains uncertain. China rarely blocks foreign deals outright, yet delays are common in sensitive areas like agriculture. Viterra’s crop marketing and Bunge’s five Chinese oilseed plants make this a major deal.
The merger cannot proceed without China's approval. This holdup highlights how global deals in food and other key sectors face strict government reviews tied to national interests.
For U.S. investors, this stall means uncertainty for Bunge’s growth plans. The $400 million fee could hit BG’s stock price should it come to pass, but a green light from China could boost shares by expanding Bunge’s reach.
Every investor in America is trying to figure out what Musk will do in Washington, D.C., in the coming weeks.
One Boston-based think tank – who has studied Elon’s work for decades – is stepping forward to share what they’ve found.
They believe his TRUE plan is far more radical than anyone realizes. It could change the way you live, work, get paid, and collect Social Security…
As foreign visitor spending slows and domestic consumers pull back, tourism and travel-related industries emerge as an underappreciated risk for the U.S. economy.
After a strong post-pandemic recovery, the U.S. travel sector has hit a wall. Major airlines have pulled financial forecasts, citing demand uncertainty.
Vacation rental and hotel companies are signaling hesitancy among travelers. Combined with a broader weakness in consumer confidence, the trend now threatens a measurable downside for GDP.
Analysts estimate that international travel spending—historically treated as a service export—could drop enough to shave up to 0.3% off U.S. output this year.
In dollar terms, that risk translates to a potential $70 billion hit to a $23 trillion economy. The shift reflects economic caution and declining inbound tourism from Europe and Asia, partly driven by friction from new U.S. tariffs.
Meanwhile, American consumers are tightening their discretionary budgets. Airline, lodging, and tourism spending trended down in early Q2, with payment data showing softness as early as March. The retreat is not limited to international markets—domestic vacation plans are also being scaled back.
The broader concern is that travel, which supports about 3% of GDP and over six million U.S. jobs, could quietly become a pressure point in an already fragile growth outlook.
With the first quarterly contraction in three years confirmed, the travel sector’s slowdown adds another layer of concern to the country’s economic picture.
On Behalf of Azincourt Energy Corp
Uranium has doubled since 2020.
Saskatchewan’s uranium sales just hit $2.6 billion, up 62% year-over-year.
Cameco says the long-term outlook has never been stronger.
Now layer on the global demand curve:
30+ countries pledging to triple nuclear capacity
AI data centers expected to use 12% of US electricity by 2028
Germany reversing course and returning to nuclear
The setup is here.
And one company has plans to drill in the heart of it all: Canada’s Athabasca Basin.
With early uranium hits, expanding alteration zones, and proximity to NexGen and Cameco, this could be the next name to watch in the sector.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
Kimberly-Clark (NYSE: KMB) will spend over $2 billion in the next five years to expand its U.S. manufacturing and logistics, the company’s biggest domestic push in 30 years.
A new one-million-square-foot factory in Warren, Ohio, will be a major hub for the Northeast and Midwest. In Beech Island, South Carolina, a new distribution center with AI-powered logistics and automation will support an existing plant. Construction for both starts this month.
These projects will create over 900 automation, robotics, and manufacturing jobs. The company also plans to upgrade its North American supply chain with new technology to move goods faster and avoid disruptions. This investment strengthens Kimberly-Clark in the U.S., which could lift its stock for investors.
By building in the U.S., Kimberly-Clark reduces risks from global supply chain issues, a trend seen across industries. This focus on high-tech facilities shows the company is planning for efficiency and growth in its home market.
The $2 billion plan signals confidence in steady profits. New jobs and advanced tech could boost KMB’s stock value by cutting costs and meeting demand faster. The scale of this move sets Kimberly-Clark apart from competitors.
Cooper Std Holdings Inc [CPS] $21.89 (+43.82%)
Cooper-Standard surged after reporting strong profit growth in Q1. Operating income soared by over 500% and adjusted EBITDA doubled from 2024 levels.
Adaptive Biotechnologies [ADPT] $9.84 (+33.70%)
Adaptive Biotechnologies increased after posting 25% revenue growth, beating estimates, cutting expenses, and raising full-year guidance.
Fulcrum Therapeutics Inc [FULC] $5.57 (+27.17%)
Fulcrum Therapeutics soared after cutting R&D expenses, advancing with its sickle cell trial, and assuring investors of cash runway into 2027.
Cable One Inc [CABO] $152.00 (-41.98%)
Cable One shares nosedived today after missing Q1 revenue and earnings estimates, posting a significant drop in subscribers and weakening margins.
Pro-Dex Inc [PDEX] $45.86 (-31.86%)
Pro-Dex stock declined despite beating earnings estimates, as revenue came in slightly below expectations and future guidance remains uncertain.
Select Medical Holdings Corp [SEM] $14.25 (-21.87%)
Select Medical fell after missing revenue and earnings estimates and reporting a sharp drop in profits compared to 2024.
On Behalf of Azincourt Energy Corp
With AI pushing power demand through the roof, nuclear is the only option.
Uranium demand is set to double. One junior may benefit most.
*Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
*Standard message/carrier rates may apply.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.